AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson’s disease

被引:0
|
作者
Friederike Freiin von Hövel
Regina Rumpel
Andreas Ratzka
Dietmar Schreiner
Claudia Grothe
机构
[1] Hannover Medical School,Institute of Neuroanatomy and Cell Biology
[2] Hannover Medical School,Center for Systems Neuroscience (ZSN)
[3] Institute of Neuroanatomy and Cell Biology,Institute for Laboratory Animal Science and Central Animal Facility
[4] Hannover Medical School,undefined
来源
Cell and Tissue Research | 2019年 / 378卷
关键词
Parkinson’s disease; AAV2/DJ; Alpha-synuclein; Rat model; E46K;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is pathologically characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and alpha-synucleinopathy. We mimic the disease pathology with overexpression of either the human α-syn wildtype (α-syn-WT) or E46K mutant form (α-syn-E46K) in DA neurons of the SNpc in adult rats using AAV2/DJ as a viral vector for the first time. Transduction efficiency was compared to an equal virus titer expressing the green fluorescent protein (GFP). Motor skills of all animals were evaluated in the cylinder and amphetamine-induced rotation test over a total time period of 12 weeks. Additionally, stereological quantification of DA cells and striatal fiber density measurements were performed every 4 weeks after injection. Rats overexpressing α-syn-WT showed a progressive loss of DA neurons with 40% reduction after 12 weeks accompanied by a greater loss of striatal DA fibers. In contrast, α-syn-E46K led to this reduction after 4 weeks without further progress. Insoluble α-syn positive cytoplasmic inclusions were observed in both groups within DA neurons of the SNpc and VTA. In addition, both α-syn groups developed a characteristic worsening of the rotational behavior over time. However, only the α-syn-WT group reached statistically significant different values in the cylinder test. Summarizing these effects, we established a motor symptom animal model of PD by using AAV2/DJ in the brain for the first time. Thereby, overexpressing of α-syn-E46K mimicked a rather pre-symptomatic stage of the disease, while the α-syn-WT overexpressing animals imitated an early symptomatic stage of PD.
引用
收藏
页码:1 / 14
页数:13
相关论文
共 50 条
  • [41] Alpha-synuclein lowering and rescue of motor phenotype by miRNA-based AAV gene therapy in an in vivo Parkinson's disease rat model
    Broekmans, S. Acar
    Erbrink, R. van Westen
    van Rooijen, C.
    Toonen, L.
    Valls, M.
    Valles, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A188 - A189
  • [42] alpha-synuclein, LRRK2 and their interplay in Parkinson's disease
    Liu, Guoxiang
    Aliaga, Leonardo
    Cai, Huaibin
    FUTURE NEUROLOGY, 2012, 7 (02) : 145 - 153
  • [43] An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
    Khodr, Christina E.
    Sapru, Mohan K.
    Pedapati, Jyothi
    Han, Ye
    West, Neva C.
    Kells, Adrian P.
    Bankiewicz, Krystof S.
    Bohn, Martha C.
    BRAIN RESEARCH, 2011, 1395 : 94 - 107
  • [44] Glycated Alpha-Synuclein and it's Emerging Role in Early Onset of Parkinson's Disease
    Chatterjee, S.
    Thakkar, H.
    Khairnar, A.
    Shah, R.
    MOVEMENT DISORDERS, 2023, 38 : S639 - S639
  • [45] Histopathological Findings in the Striatum and Substantia Nigra in a Rat Model of Parkinson's Disease
    Isajevs, S.
    Isajeva, D.
    Pupure, J.
    Rumaks, J.
    Svirskis, S.
    Dzirkale, Z.
    Jansone, B.
    Klusa, V.
    LABORATORY INVESTIGATION, 2012, 92 : 431A - 431A
  • [46] Histopathological Findings in the Striatum and Substantia Nigra in a Rat Model of Parkinson's Disease
    Isajevs, S.
    Isajeva, D.
    Pupure, J.
    Rumaks, J.
    Svirskis, S.
    Dzirkale, Z.
    Jansone, B.
    Klusa, V.
    MODERN PATHOLOGY, 2012, 25 : 431A - 431A
  • [47] Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson’s Disease Mouse Model
    Min Hyung Seo
    Sujung Yeo
    Molecular Neurobiology, 2023, 60 : 780 - 788
  • [48] Growth differentiation factor 5 exerts neuroprotection in an alpha-synuclein rat model of Parkinson's disease
    Goulding, Susan R.
    Concannon, Ruth M.
    Morales-Prieto, Noelia
    Villalobos-Manriquez, Francisca
    Clarke, Gerard
    Collins, Louise M.
    Levesque, Martin
    Wyatt, Sean L.
    Sullivan, Aideen M.
    O'Keeffe, Gerard W.
    BRAIN, 2021, 144
  • [49] Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model
    Seo, Min Hyung
    Yeo, Sujung
    MOLECULAR NEUROBIOLOGY, 2023, 60 (02) : 780 - 788
  • [50] Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson's Disease
    Jewett, Michael
    Dickson, Elna
    Brolin, Kajsa
    Negrini, Matilde
    Jimenez-Ferrer, Itzia
    Swanberg, Maria
    FRONTIERS IN NEUROLOGY, 2018, 9